GastroPanel®

About Biohit

Biohit Oyj is a publicly traded Finnish diagnostics company with a 35+ year legacy focused on preventing illnesses through innovative in vitro diagnostics. Its core achievement is the development and global commercialization of GastroPanel®, a blood test for stomach health assessment and gastric cancer risk stratification. The company's strategy centers on expanding the adoption of its proprietary tests in primary care settings and integrating them into national screening programs, leveraging its direct commercial subsidiaries in Italy and the UK.

Therapeutic Areas